The establishment of several continuously proliferating cell lines has greatly facilitated research into cellular differentiation and has increased our understanding of leukocyte proliferative disorders, in particular leukaemia. One such cell line is HL-60 [l] . This human promyelocytic cell line has been used not only in studies of myeloid differentiation, but also as an immunogen for the production of monoclonal antibodies, which have had many applications in leukaemia research and have done much to increase our knowledge of the leukaemic condition.
In a previous publication, we described the production and classification of a monoclonal antibody, NC-2, to an unusual surface protein expressed on the HL-60 cell line, but present on no other cell line examined [2] . This antibody was subsequently shown to react wtih leukocytes from 5% of normal individuals, with a much higher percentage (35%) of leukaemia patients reacting. On the basis of these data there appeared to be a link between the expression of this particular antigen and the incidence of leukaemia (31. Links between the expression of specific cell surface antigens and a variety of diseases have already been established. In the present study, we have focused on the biochemical characterization and cellular distribution of the alloantigen reacting with NC-2 and have shown it to be a proteinase-sensitive glycoprotein which is present, not only in the plasma membrane, but also in the cytoplasm of reacting cells.
SDS/PAGE analysis of 1251-labelled HL-60 cell surface proteins, which had been immunoprecipitated with NC-2, showed two major bands, at 50 kDa and 15 kDa in a 12.5% (w/v) gel ( Fig. la; lane A) . In addition, there was some material of much higher molecular mass which failed t o enter this gel or gels made with a lower percentage (7%, w/v) polyacrylamide. The 15 kDa protein is unlikely to be a catabolic fragment of the SO kDa protein, since a large range of pro- 
Vol. 18
BIOCHEMICAL SOCIETY TRANSACTIONS teinase inhibitors was included in the lysing solution. To preclude the precipitation of non-specific material, lysates were pre-cleared twice with goat anti-( mouse IgG)agarose, followed by incubation with NB-1, an irrelevant antibody [4] .
Digestion of immunoprecipitated antigen for 4 h with trypsin at a final concentration of 1 mg/ml resulted in bands at 21 kDa, 16.5 kDa, 11.5 kDa, 10 kDa, 7.5 kDa and 5.8 kDa ( Fig. la; lane B) . Non-digested NC-2 immunoprecipitates incubated at 37°C for 4 h exhibited the usual banding pattern, demonstrating that fragmentation was indeed due to the addition of trypsin and not due to proteolysis by enzymes present within the lysate.
lmmunoprecipitated antigen was digested with 2.0 m-units of glycopeptidase F, an enzyme which hydrolyses all classes of asparagine-linked glycans, provided that both the aamino acid and carboxyl groups of the asparagine residues are present in a peptide linkage [S] . Digestion resulted in the usual bands and two additional bands, with molecular masses of 46 kDa and 38 kDa (Fig. 16) . The persistence of the 50 kDa band in glycopeptidase F-digested material may indicate that the reaction did not proceed to completion. However, repetition of the experiment using 5.0 m-units of the glycosidase resulted in a banding pattern identical to that obtained in the experiment in which 2.0 m-units of glycopeptidase F was used. Treatment of immunoprecipitated antigen with neuraminidase for 18 h did not visibly alter the mobility of the 50 kDa band in the gel, suggesting that the antigen is a glycoprotein without a large amount of sialic acid residues, while the glycopeptidase F digests indicate the presence of N-linked oligosaccharides.
We have examined the reactivity of the NC-2 antigen with cells from a variety of normal human tissues using the 'APAAP' immunocytochemical staining technique [6] . h epared slides were obtained commercially, each containing tissue sections from ovary, testis, thyroid, pancreas, lung, heart, kidney, liver, spleen, adrenal glands and gastrointestinal tract. Some degree of positive staining was observed in all except thyroid, pancreas, lung and spleen.
We have used immunofluorescence techniques to examine the internal location of the antigen and compare its distribution with that of a number of other well-characterized antigens expressed in HL-60 cells. Cells to be assayed for immunofluorescence were applied to microscope slides by cytocentrifugation, a process which flattens cells to some extent, enabling more internal detail to be distinguished than in unflattened cells. Antibodies directed against the X-hapten and a-tubulin respectively, produced staining patterns very distinct from that of NC-2. The pattern most similar to that of NC-2 was produced by the granulocytespecific antibody termed 82H 1, thought to be directed against carbohydrate sequences, some of which are present on the same 180 kDa protein as the X-hapten, although it has been shown not to be an anti-X antibody [7] . The pattern produced by NC-2 was granular, with distinct fluorescent spots visible internally. These fluorescent spots appear to be randomly distributed in the cytoplasm, suggesting a localization within granules. A similar pattern was observed by Baldari & Telford using a monoclonal antibody specific for a lysosomal antigen [8] .
The biochemical analysis and the subcellular localization studies of the NC-2-reacting antigen presented here provide the basis for future studies to discern the functional role of this glycoprotein.
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Introduction
Clofazimine (B663), a red iminophenazine dye [ 11, is very effective in the treatment of leprosy. Its mode of action is thought to be due to its inhibition of the template function of DNA. Resistance to the anti-leprosy agents rifampicin and dapsone has been widely reported and in 1982 a case of clofazimine-resistant leprosy was described [ 21. Hence, a number of analogues of clofazimine were synthesized in order to develop agents that might overcome such resistance [3-51. Studies on clofazimine and analogues were performed to determine which compounds had the required absorption characteristics in mice. The use of h.p.1.c. for the analysis of clofazimine and analogues was also investigated.
Materials and methoa's
Clofazimine and derivatives were synthesized as previously described [5]. The drugs were made up and thoroughly homogenized in 0.5% (w/v) carboxymethyl-cellulose and 0.5% (v/v) Tween 20. Animals (8-10-week-old Schofield mice) received a daily dosage of 20 mg day ' kg -I by gavage (0.4 ml) over a period of 3 weeks using a modified 5 cm human spinal needle. After 21 days the mice were killed. The lungs, liver, spleen and pelvic fat were removed and weighed. They were then placed in pre-weighed 5 ml Bijou bottles containing 0.5 ml of 25% (v/v) acetic acid. Organs were pooled, if appropriate. Serum samples were also taken. All samples were stored at -20°C. For drug extractions tissues were finely chopped, homogenized in 25% (v/v) acetic acid in a Elvehjem homogenizer and then carefully extracted ( x 4) with chloroform or other appropriate solvent, followed by 50% (v/v) phosphoric acid or hydrochloric acid [6] . Groups of three to six mice were used for each drug studied. The amount of drug extracted was then determined spectro-
